Leadless Pacemaker Registry: Outcomes and Follow-up From the University Hospital of St. Pölten
NCT ID: NCT07246135
Last Updated: 2025-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
700 participants
OBSERVATIONAL
2015-06-18
2035-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a single-center, prospective and retrospective registry that includes all patients receiving a leadless pacing device, as well as all patients who received a leadless pacing device between January 2021 and the start of the registry. All patients undergoing implantation of a leadless pacemaker will be invited to participate in the registry. For patients to be included retrospectively, participation in the registry will be offered at the time of their next routine follow-up visit.
The indication for leadless pacing will be determined by the physician responsible for the patient. Enrollment in the registry will in no case alter or influence the treatment the patient receives. Data collection will take place at the time of implantation and continuously during follow-up over the entire study period. Pacemaker-related data may be obtained either in person or via remote monitoring.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome of Patients Undergoing Leadless Pacemaker Implantaton
NCT06656468
Taiwan Registry for Leadless Pacemaker
NCT04926792
AVEIR™ Leadless Pacemaker Registry in Europe and MIddle East Region (PREMIER LEADLESS)
NCT06782152
Left Ventricular Function and Remodelling During Permanent Pacing
NCT00228241
Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator Procedures
NCT01717495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who previously received a leadless pacemaker between June 2015 and the start of the registry (retrospective inclusion).
* Age ≥ 18 years.
* Written informed consent provided by the patient.
Exclusion Criteria
* Patients in whom a conventional transvenous pacemaker is implanted (i.e., not leadless).
* Any condition that, in the opinion of the treating physician, precludes participation in the registry.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital St. Polten
OTHER
Karl Landsteiner University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julia Mascherbauer, MD, Professor
Role: PRINCIPAL_INVESTIGATOR
Department of Internal Medicine III, University Hospital of St. Pölten
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of St. Pölten
Sankt Pölten, Lower Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GS3-EK-4/899-2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.